Abstract:Diabetes Mellitus is a global health problem affecting 422 million people worldwide, of which 34.2 million live in the United States alone. Complications due to diabetes can lead to considerable morbidity and mortality related to both micro‐ and macro‐ vascular disease. While Hemoglobin A1c testing is the standard test utilized to evaluate glycemic control, emerging targets like "time in range" and "glycemic variability" often provide more accurate assessments of glycemic fluctuations and have implications for diabetes complications and quality of life. Patients with diabetes face considerable burdens of self‐care including frequent glucose monitoring, multiple insulin injections, dietary management, and the need to track daily activities, all of which lead to reduced adherence and psychological burn‐out. From the provider perspective, limited patient data and access to self‐management tools leads to treatment inertia and a reduced ability to help patients achieve and maintain their glycemic goals. In the past few decades, there have been considerable advances in treatment based technology and technological applications designed to help reduce patient burden and provide tools for better self‐management. These advances make real‐time clinical data available for clinicians to make necessary changes in treatment regimens. In this review, we discuss the latest emerging technologies available for the management of people with type 2 Diabetes Mellitus.

Emerging technologies for the management of type 2 diabetes mellitus